Advertisement
 

doctorslounge.com

 
Powered by
Careerbuilder

 

                    Home  |  Forums  |  Humor  |  Advertising  |  Contact
   Ask a Doctor

   News via RSS

   Newsletter

   Cardiology

   News

   Conferences

   CME

   Forum Archives

   Diseases

   Symptoms

   Labs

   Procedures

   Drugs

   Links
   Specialties

   Cardiology

   Dermatology

   Endocrinology

   Fertility

   Gastroenterology

   Gynecology

   Hematology

   Infections

   Nephrology

   Neurology

   Oncology

   Orthopedics

   Pediatrics

   Pharmacy

   Primary Care

   Psychiatry

   Pulmonology

   Rheumatology

   Surgery

   Urology

   Other Sections

   Membership

   Research Tools

   Medical Tutorials

   Medical Software

 

 Headlines:

 
 

Back to Cardiovascular Diseases

Brugada syndrome

Brugada syndrome, also known as Sudden Unexpected Death Syndrome (SUDS), is the most common cause of sudden death in young men without known underlying cardiac disease. It is due to a dysfunction of the myocardial voltage-gated sodium channels which renders patients vulnerable to ventricular tachycardia and/or fibrillation that often results in sudden cardiac death.

Causes

Dysfunction in cardiac ion channels underlies the clinical manifestations of Brugada syndrome (i.e. cardiac channelopathy). About 20% have mutations in the gene SCN5A, which encodes the cardiac voltage-gated sodium channel Nav1.5. This leads to a loss of the action potential dome of some epicardial areas of the right ventricle. Which results in transmural and epicardial dispersion of repolarization. The transmural dispersion underlies ST-segment elevation and the development of a vulnerable window across the ventricular wall, whereas the epicardial dispersion of repolarization facilitates the development of phase 2 reentry, which generates a phase 2 reentrant extrasystole that captures the vulnerable window to precipitate ventricular tachycardia and/or fibrillation that often results in sudden cardiac death.

This condition is inherited in an autosomal dominant pattern in 50% of familial cases and is more common in males. In addition it has a higher prevalence in most Asian populations (e.g. Laos and Thailand).

Symptoms and signs

Patients with Brugada syndrome are prone to develop ventricular tachyarrhythmias, which may lead to syncope, cardiac arrest, or sudden cardiac death.

Diagnosis

In some cases, the disease can be detected by observing characteristic patterns on an electrocardiograph, which may be present all the time, or might be elicited by strenuous exercise, or by the administration of particular drugs (infusion of flecainide, procainamide or a beta-blocker). In these cases, the disorder is characterized by a complete or incomplete right bundle-branch block and T-wave inversion with a characteristic coved or saddle-shaped ST-segment elevation in leads V1 through V3 on ECG.

Treatment

1. Implantable cardiac defibrillator (ICD)

At present, implantation of an implantable cardiac defibrillator (ICD) is the only treatment that has been proven effective for Brugada syndrome. This is indicated for patients who have a history of cardiac arrest and those with a high risk of sudden death.

advertisement.gif (61x7 -- 0 bytes)
 

Are you a doctor or a nurse?

Do you want to join the Doctors Lounge online medical community?

Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients.

Click on the link below to see the requirements:

Doctors Lounge Membership Application


previous.gif (72x17 -- 347 bytes) next.gif (72x17 -- 277 bytes)
 

 advertisement.gif (61x7 -- 0 bytes)

 

 



We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright 2001-2012 DoctorsLounge. All rights reserved.